Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
NCT ID: NCT02573545
Last Updated: 2019-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
148 participants
INTERVENTIONAL
2013-01-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* a facilitation of the planning stages of the procedure (route path, marking of the entry point and alignment of the MRI cutaways on the planned path), resulting in a reduction in the duration of the planning stages,
* a facilitation of the real-time modification of MRI cutaways during the procedure, resulting in a reduction of the duration of the procedure
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Quantification of Liver Iron With MRI
NCT02425956
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
NCT03245606
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound
NCT02044523
Robotic-assisted Percutaneous Transhepatic Puncture
NCT06195917
Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation
NCT04123340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group: with IFE
Patients treated with IFE software
Planning@IFE and Standard@IFE Software
Test group: without IFE
Patients treated with Numaris 4 software
MR Syngo (Numaris/4) software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Planning@IFE and Standard@IFE Software
MR Syngo (Numaris/4) software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliated to a social security scheme
* Informed consent
* Patient with an indication of liver biopsy eligible for a biopsy under interventional MRI
Exclusion Criteria
* Patient with a contraindication for performing a biopsy
* Pregnancy
* Exclusion period
* Patient unable to receive and understand information about the study
* Patients under guardianship
* Patients under judicial protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nouvel Hôpital civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5261
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.